Drawing for &

USPTO serial 88980006

&

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SALES, HEATHER ALISON
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with &?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kamran Fattahi

Kamran Fattahi Law Offices of Kamran Fattahi15303 Ventura Blvd., Suite 900Sherman Oaks, CA 91403United States

Goods and services

ClassDescriptionStatusFirst use
003Essential oils for cosmetic purposes containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Cosmetics containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Cosmetics, namely, non-medicated body oils containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Cosmetics, namely, non-medicated body ointments containing lavender, mint, cardamom, ginger, myrrh, and spearmint, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, containing lavender, mint, cardamom, ginger, myrrh, and spearmint, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Non-medicated body soaks containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Electronic cigarette liquid (e-liquid) comprised of essential oils, containing lavender, mint, cardamom, ginger, myrrh, and spearmintACTIVE—
005Mentholated ointment for medical use containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Medicated skin oils containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Topical analgesics containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Analgesic balm containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Medicated skin creams and lotions containing lavender, mint, cardamom, ginger, myrrh, and spearmint; medicated skin care preparations containing lavender, mint, cardamom, ginger, myrrh, and spearmint; medicated herbal topical creams, gels, skin sprays, balms, liniment and ointments, all for the relief of pain, containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Topical gel for medical and therapeutic treatment of minor aches and pains of muscles and joints, containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Nutritional supplements in drop form, capsule form, and liquid form, containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Herbal tinctures for medical purposes containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Medicated oral spray for pain containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Nutritional supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in managing and addressing stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Pharmaceutical, medicinal, medicated herbal, medicated botanical, and medicated preparations in the form of salves, concentrates, pastes, extracts, tinctures, and mucous membrane doses, for use in acting upon or caring for pain, muscle tension, muscle spasms, and gastrointestinal illness, containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, containing lavender, mint, cardamom, ginger, myrrh, and spearmint; Muscle soaks containing lavender, mint, cardamom, ginger, myrrh, and spearmintACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 24, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 24, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 24, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 24, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 24, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 30, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 29, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 29, 2025EX5MSOU EXTENSION 5 DENIAL LETTER MAILED—
Jan 29, 2025EX5DSOU EXTENSION 5 DENIAL LETTER PREPARED—
Jan 6, 2025IROARESPONSE TO ITU OFFICE ACTION ENTERED—
Jan 6, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2024INCEITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST—
Dec 11, 2024IROARESPONSE TO ITU OFFICE ACTION ENTERED—
Dec 11, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2024INCEITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST—
Nov 20, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 18, 2024EXT5SOU EXTENSION 5 FILED—
Nov 18, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 18, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 18, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 18, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 23, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 22, 2024EX4GSOU EXTENSION 4 GRANTED—
Apr 22, 2024EXT4SOU EXTENSION 4 FILED—
Apr 22, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 16, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 14, 2023EX3GSOU EXTENSION 3 GRANTED—
Nov 14, 2023EXT3SOU EXTENSION 3 FILED—
Nov 14, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 18, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 16, 2023EX2GSOU EXTENSION 2 GRANTED—
May 16, 2023EXT2SOU EXTENSION 2 FILED—
May 16, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 18, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 16, 2022EX1GSOU EXTENSION 1 GRANTED—
Nov 16, 2022EXT1SOU EXTENSION 1 FILED—
Nov 16, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 22, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 22, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 2, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 11, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 30, 2021GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Apr 30, 2021GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Apr 30, 2021EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Apr 30, 2021CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Mar 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 10, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 5, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 4, 2021DPCCDIVISIONAL PROCESSING COMPLETE—
Dec 15, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 15, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2020DRRRDIVISIONAL REQUEST RECEIVED—
Dec 14, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 14, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 14, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 14, 2020JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Dec 14, 2020EXPIEX PARTE APPEAL-INSTITUTED—
Dec 14, 2020EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Dec 14, 2020ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Dec 13, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 13, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 13, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 13, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 12, 2020DPCCDIVISIONAL PROCESSING COMPLETE—
May 11, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 11, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 4, 2020ALIEASSIGNED TO LIE—
Apr 29, 2020DRRRDIVISIONAL REQUEST RECEIVED—
Apr 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2020ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Oct 29, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2019DOCKASSIGNED TO EXAMINER—
May 6, 2019DOCKASSIGNED TO EXAMINER—
May 6, 2019DOCKASSIGNED TO EXAMINER—
Mar 21, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 15, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 28, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance